VX-5

N/A

Report date: 2025/05/14 16:47:16

Base Information

Drug NameVX-5
Drug Alias NameVX-5VX5/5261VX5/5261-muIg
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody human
Mechanisms of ActionC-X-C motif chemokine 13 inhibitors
TargetsC-X-C motif chemokine 13
Therapy Area/IndicationsAutoimmune DiseasesMultiple SclerosisAutoimmune Diseases of the Nervous System +[6] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesVaccinex Inc
China Registration ClassN/A

Develop Information

Active CompaniesVaccinex Inc
Inactive CompaniesN/A
Active IndicationsAutoimmune DiseasesMultiple SclerosisAutoimmune Diseases of the Nervous System +[6] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A